Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Horse chestnut seed extract to improve microcirculation in diabetic patients
DRKS00031074Phase 2Completed
- Sponsor
- Cesra
- Start
- Jan 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Aescuven with Placebo (2 arms). Started Jan 2023; status: completed.
02
Drugs
aescuven
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on DRKS00031074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00031074.